Lunaphore Technologies S.A., now under the Bio-Techne Spatial brand, is a promising player in the biotechnology and life sciences domains. Established in 2014 and headquartered in Switzerland, Lunaphore has developed innovative chip technology that enables spatial proteomic and genomic analysis, paving the way for advanced personalized therapies.
By transforming simple assays into multiplex spatial biology, Lunaphore is pushing the frontiers of research with its groundbreaking technology. This capability strongly aligns with the industry's growing focus on personalized medicine and spatial biology, positioning the company to capture substantial market opportunities.
Their most recent financial activity involved a Fr.10.00M debt financing round on March 23, 2023, supported by Norginer Ventures. As a brand under Bio-Techne, Lunaphore is further empowered to integrate its cutting-edge advances within the expansive capabilities of its parent company. This strategic acquisition enhances their potential to make significant inroads into global markets.